397030 — AprilBio Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩308bn
- KR₩251bn
Annual cashflow statement for AprilBio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | — | -10,220 | -52,713 | -8,959 | -14,130 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | — | 1,351 | 57,511 | -1,873 | 1,690 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2,524 | 1,179 | -2,033 | 3,535 | 1,707 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2,524 | -7,329 | 3,252 | -6,704 | -10,059 |
| Capital Expenditures | -684 | -480 | -706 | -89.6 | -512 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -548 | -6,557 | -23,094 | -31,552 | -6,542 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,233 | -7,037 | -23,800 | -31,642 | -7,054 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -47.1 | 17,880 | 34,793 | 20,328 | 16,312 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3,804 | 3,515 | 14,245 | -17,093 | -697 |